0001179110-18-005443.txt : 20180404
0001179110-18-005443.hdr.sgml : 20180404
20180404201456
ACCESSION NUMBER: 0001179110-18-005443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180402
FILED AS OF DATE: 20180404
DATE AS OF CHANGE: 20180404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bukofzer Stan
CENTRAL INDEX KEY: 0001663041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13111
FILM NUMBER: 18738769
MAIL ADDRESS:
STREET 1: C/O OCERA THERAPEUTICS
STREET 2: 525 UNIVERSITY AVENUE, SUITE 610
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEPOMED INC
CENTRAL INDEX KEY: 0001005201
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943229046
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD.
STREET 2: SUITE 300
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-744-8000
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD.
STREET 2: SUITE 300
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
edgar.xml
FORM 4 -
X0306
4
2018-04-02
0
0001005201
DEPOMED INC
DEPO
0001663041
Bukofzer Stan
C/O DEPOMED, INC 7999 GATEWAY BLVD
SUITE 300
NEWARK
CA
94560
0
1
0
0
Chief Medical Officer & SVP***
Restricted Stock Units
2018-04-02
4
A
0
91324
0
A
Common Stock
91324
91324
D
Each Restricted Stock Unit represents the contingent right to receive one share of common stock upon vesting of the unit.
These Restricted Stock Units are scheduled to vest 27.78% on April 2, 2019, 27.78% on April 2, 2020 and 44.44% on April 2021 assuming continued employment through the applicable vesting date.
*** Stanley's title is Chief Medical and Scientific Officer, Senior Vice President.
Stanley Bukofzer
2018-04-04